The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial Fibrillation
1 other identifier
interventional
31
1 country
1
Brief Summary
This study seeks to determine the efficacy of single coil defibrillation leads for cardioversion of persistent atrial fibrillation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable atrial-fibrillation
Started Jul 2017
Shorter than P25 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2017
CompletedFirst Posted
Study publicly available on registry
May 23, 2017
CompletedStudy Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2018
CompletedMarch 22, 2019
March 1, 2019
1.3 years
May 21, 2017
March 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acute Conversion of Atrial Fibrillation to Sinus Rhythm
Does the patient return for at least one beat to sinus rhythm following the administration of a shock
Immediate
Study Arms (2)
Internal Cardioversion
EXPERIMENTALPatients randomized to external cardioversion will undergo external synchronized cardioversion per institutional protocol.
External Cardioversion
ACTIVE COMPARATORPatients randomized to internal cardioversion will have a maximum energy shock delivered from the device between the RV coil and can. If cardioversion is not successful they will then undergo external cardioversion per institutional protocol.
Interventions
Internal Cardioversion with device maximum output shock from RV coil to Can versus external cardioversion per institutional protocol
External Cardioversion per institutional protocol
Eligibility Criteria
You may qualify if:
- greater than 18 years of age
- persistent atrial fibrillation and have been recommended by your primary cardiologist to undergo cardioversion
- have an implantable cardiac defibrillator
You may not qualify if:
- over the age of 99
- pregnant
- prisoner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40506, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Samy C Elayi, MD
University of Kentucky
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 21, 2017
First Posted
May 23, 2017
Study Start
July 1, 2017
Primary Completion
October 23, 2018
Study Completion
October 23, 2018
Last Updated
March 22, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share